 |
|
|
|
 |
|
|
| Article 1 to 7 out of 7 concerning Nanogen, Inc.
|
-
Nanogen Announces Collaboration with Canadian Agencies to Develop Veterinary and Bioterror Diagnostics
(06/15/2007)
Nanogen, Inc. announced that it has received project funding from several Canadian agencies, including the Canadian Food Inspection Agency (CFIA). The purpose of the funding and collaborative agreement is to develop diagnostic tools for the ...
-
Fisher Scientific to Acquire Athena Diagnostics from Behrman Capital and Purchase 9 Percent of Nanogen
(03/20/2006)
Company Expands Presence in Molecular Diagnostics
Fisher Scientific International Inc. announced two transactions that will significantly enhance its capabilities in molecular diagnostics. Fisher has entered into a definitive agreement to acquire privately held Athena Diagnostics, Inc., developer ...
-
SynX Granted Key European Patent for Stroke Diagnostic
(12/02/2004)
Nanogen, Inc. announced its SynX subsidiary was issued European Patent "Method for Diagnosing and Distinguishing Stroke" by the European Patent Office. This patent relates to a diagnostic kit and method of measuring the presence of both an ischemic ...
-
Nanogen Announces Clinical Diagnostic to Simultaneously Detect Multiple Respiratory Viruses
(11/12/2004)
Nanogen, Inc., is developing new analyte specific reagents (ASRs) for clinical reference laboratories to develop and validate a single test to detect six of the most common respiratory viruses. Instead of testing for multiple viruses using ...
-
Nanogen Issued Patent for Addressable Biologic Electrode Arrays
(01/29/2004)
Nanogen, Inc. announced that it was issued U.S. Patent "Addressable Biologic Electrode Array," by the U.S. Patent and Trademark Office. The '936 patent relates to electrode-based array devices and methods of operation in which individual electrodes ...
-
Nanogen Issued Key Nanotechnology Patent
(12/10/2003)
Newly Issued Patent Broadens Proprietary Position in Nanomanufacturing and Nanotechnology
Nanogen, Inc. announced that it has been issued the U.S. Patent "Methods for the Electronic Assembly and Fabrication of Devices," ("the '808 patent") by the U.S. Patent and Trademark Office. This patent is the parent of a series of pending patent ...
-
Nanogen and Prodesse to develop infectious disease diagnostics
(09/12/2003)
Nanogen, Inc. and Prodesse, Inc. announced the signing of a collaboration agreement to develop automated, highly sensitive microarray- based products to detect a number of infectious disease agents, including influenza, pneumonia, adenovirus, ...
Additional information
Nanogen, Inc.
San Diego, CA, United States of America
Company
|
|
|
|
|
|
Top
